

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hypotonic response (GO:0006971) | 4.95480871 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 4.91627953 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.91627953 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.72334361 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.72334361 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.37992358 |
| 7 | regulation of response to osmotic stress (GO:0047484) | 4.20731002 |
| 8 | protein localization to endosome (GO:0036010) | 4.18597687 |
| 9 | valine metabolic process (GO:0006573) | 4.18019440 |
| 10 | lysine catabolic process (GO:0006554) | 4.12838942 |
| 11 | lysine metabolic process (GO:0006553) | 4.12838942 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 4.12529394 |
| 13 | regulation of triglyceride catabolic process (GO:0010896) | 4.11433043 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 4.10695731 |
| 15 | ethanol oxidation (GO:0006069) | 4.07341796 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95763251 |
| 17 | glyoxylate metabolic process (GO:0046487) | 3.95377896 |
| 18 | skin morphogenesis (GO:0043589) | 3.89291323 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.86544199 |
| 20 | kynurenine metabolic process (GO:0070189) | 3.81511196 |
| 21 | cysteine metabolic process (GO:0006534) | 3.79277710 |
| 22 | protein retention in ER lumen (GO:0006621) | 3.75384424 |
| 23 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.74757735 |
| 24 | tryptophan catabolic process (GO:0006569) | 3.72824257 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 3.72824257 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 3.72824257 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 3.70019770 |
| 28 | barbed-end actin filament capping (GO:0051016) | 3.65436906 |
| 29 | regulation of early endosome to late endosome transport (GO:2000641) | 3.61849826 |
| 30 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61059564 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.52885194 |
| 32 | protein carboxylation (GO:0018214) | 3.52885194 |
| 33 | tryptophan metabolic process (GO:0006568) | 3.52211460 |
| 34 | COPI coating of Golgi vesicle (GO:0048205) | 3.48121325 |
| 35 | Golgi transport vesicle coating (GO:0048200) | 3.48121325 |
| 36 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.47903383 |
| 37 | glycine metabolic process (GO:0006544) | 3.46094405 |
| 38 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.44776547 |
| 39 | serine family amino acid biosynthetic process (GO:0009070) | 3.44689882 |
| 40 | 2-oxoglutarate metabolic process (GO:0006103) | 3.40856031 |
| 41 | tricarboxylic acid metabolic process (GO:0072350) | 3.38962992 |
| 42 | cell-substrate adherens junction assembly (GO:0007045) | 3.38901988 |
| 43 | focal adhesion assembly (GO:0048041) | 3.38901988 |
| 44 | cell-substrate junction assembly (GO:0007044) | 3.38860103 |
| 45 | fatty acid beta-oxidation (GO:0006635) | 3.38840146 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.38578661 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38578661 |
| 48 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.37513962 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 3.36708604 |
| 50 | bile acid biosynthetic process (GO:0006699) | 3.35541298 |
| 51 | pinocytosis (GO:0006907) | 3.34784022 |
| 52 | stress fiber assembly (GO:0043149) | 3.31775242 |
| 53 | adherens junction assembly (GO:0034333) | 3.29760864 |
| 54 | positive regulation of extracellular matrix organization (GO:1903055) | 3.29411979 |
| 55 | regulation of extracellular matrix disassembly (GO:0010715) | 3.27758960 |
| 56 | aldehyde catabolic process (GO:0046185) | 3.25403742 |
| 57 | branched-chain amino acid catabolic process (GO:0009083) | 3.22405538 |
| 58 | carnitine metabolic process (GO:0009437) | 3.22350267 |
| 59 | branched-chain amino acid metabolic process (GO:0009081) | 3.22130181 |
| 60 | high-density lipoprotein particle remodeling (GO:0034375) | 3.20260085 |
| 61 | fatty acid oxidation (GO:0019395) | 3.16984468 |
| 62 | cellular modified amino acid catabolic process (GO:0042219) | 3.16711250 |
| 63 | complement activation, alternative pathway (GO:0006957) | 3.14965292 |
| 64 | basement membrane organization (GO:0071711) | 3.14931130 |
| 65 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.13545491 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 3.13371463 |
| 67 | aromatic amino acid family metabolic process (GO:0009072) | 3.12651171 |
| 68 | negative regulation of fatty acid transport (GO:2000192) | 3.12387140 |
| 69 | lipid oxidation (GO:0034440) | 3.12164138 |
| 70 | 4-hydroxyproline metabolic process (GO:0019471) | 3.11920825 |
| 71 | homocysteine metabolic process (GO:0050667) | 3.10286114 |
| 72 | serine family amino acid catabolic process (GO:0009071) | 3.09651144 |
| 73 | regulation of cholesterol esterification (GO:0010872) | 3.08937304 |
| 74 | ethanol metabolic process (GO:0006067) | 3.08061372 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 3.07696388 |
| 76 | fatty acid catabolic process (GO:0009062) | 3.07614126 |
| 77 | pentose-phosphate shunt (GO:0006098) | 3.07368266 |
| 78 | cell volume homeostasis (GO:0006884) | 3.05831619 |
| 79 | regulation of cholesterol metabolic process (GO:0090181) | 3.03442439 |
| 80 | reverse cholesterol transport (GO:0043691) | 3.03432580 |
| 81 | regulation of triglyceride metabolic process (GO:0090207) | 3.03406907 |
| 82 | primary alcohol catabolic process (GO:0034310) | 3.02738195 |
| 83 | positive regulation of nuclease activity (GO:0032075) | 3.01896798 |
| 84 | L-serine metabolic process (GO:0006563) | 3.00256137 |
| 85 | vesicle coating (GO:0006901) | 2.99851890 |
| 86 | proline biosynthetic process (GO:0006561) | 2.99549242 |
| 87 | biotin metabolic process (GO:0006768) | 2.98177823 |
| 88 | plasma lipoprotein particle remodeling (GO:0034369) | 2.97776752 |
| 89 | protein-lipid complex remodeling (GO:0034368) | 2.97776752 |
| 90 | macromolecular complex remodeling (GO:0034367) | 2.97776752 |
| 91 | mannose metabolic process (GO:0006013) | 2.97431354 |
| 92 | tyrosine metabolic process (GO:0006570) | 2.97131874 |
| 93 | regulation of fibrinolysis (GO:0051917) | 2.96025222 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 2.95352521 |
| 95 | alpha-amino acid catabolic process (GO:1901606) | 2.94397660 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 2.93290152 |
| 97 | response to nitrosative stress (GO:0051409) | 2.92643040 |
| 98 | NADPH regeneration (GO:0006740) | 2.91502883 |
| 99 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.91433021 |
| 100 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.91188078 |
| 101 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.89612601 |
| 102 | regulation of cholesterol homeostasis (GO:2000188) | 2.88921792 |
| 103 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.88499354 |
| 104 | urea metabolic process (GO:0019627) | 2.88474406 |
| 105 | urea cycle (GO:0000050) | 2.88474406 |
| 106 | regulation of protein activation cascade (GO:2000257) | 2.87928069 |
| 107 | plasma lipoprotein particle assembly (GO:0034377) | 2.87902568 |
| 108 | monocarboxylic acid catabolic process (GO:0072329) | 2.87630524 |
| 109 | apoptotic cell clearance (GO:0043277) | 2.87488851 |
| 110 | cortical cytoskeleton organization (GO:0030865) | 2.85883307 |
| 111 | cellular ketone body metabolic process (GO:0046950) | 2.85627194 |
| 112 | positive regulation of receptor recycling (GO:0001921) | 2.84377746 |
| 113 | phospholipid efflux (GO:0033700) | 2.84322662 |
| 114 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.81923876 |
| 115 | hemidesmosome assembly (GO:0031581) | 2.81443813 |
| 116 | nitrogen cycle metabolic process (GO:0071941) | 2.81294703 |
| 117 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.80732239 |
| 118 | cellular amino acid catabolic process (GO:0009063) | 2.79659146 |
| 119 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.79372211 |
| 120 | modulation by symbiont of host cellular process (GO:0044068) | 2.78279297 |
| 121 | low-density lipoprotein particle remodeling (GO:0034374) | 2.77943209 |
| 122 | maternal placenta development (GO:0001893) | 2.77765784 |
| 123 | negative regulation of cell size (GO:0045792) | 2.77645391 |
| 124 | negative regulation of sterol transport (GO:0032372) | 2.76887076 |
| 125 | negative regulation of cholesterol transport (GO:0032375) | 2.76887076 |
| 126 | regulation of complement activation (GO:0030449) | 2.76303029 |
| 127 | bile acid metabolic process (GO:0008206) | 2.75623344 |
| 128 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.74023490 |
| 129 | carboxylic acid catabolic process (GO:0046395) | 2.73706444 |
| 130 | organic acid catabolic process (GO:0016054) | 2.73706444 |
| 131 | hyaluronan catabolic process (GO:0030214) | 2.71036205 |
| 132 | cell adhesion mediated by integrin (GO:0033627) | 2.68690469 |
| 133 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.67910017 |
| 134 | low-density lipoprotein particle clearance (GO:0034383) | 2.67902597 |
| 135 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.67694679 |
| 136 | COPII vesicle coating (GO:0048208) | 2.67167437 |
| 137 | drug transmembrane transport (GO:0006855) | 2.66847215 |
| 138 | response to laminar fluid shear stress (GO:0034616) | 2.66641238 |
| 139 | ketone body metabolic process (GO:1902224) | 2.65742979 |
| 140 | acylglycerol homeostasis (GO:0055090) | 2.65640446 |
| 141 | triglyceride homeostasis (GO:0070328) | 2.65640446 |
| 142 | regulation of nuclease activity (GO:0032069) | 2.65435446 |
| 143 | ER-nucleus signaling pathway (GO:0006984) | 2.65327708 |
| 144 | embryonic process involved in female pregnancy (GO:0060136) | 2.64410361 |
| 145 | protein-lipid complex assembly (GO:0065005) | 2.63621745 |
| 146 | acetyl-CoA metabolic process (GO:0006084) | 2.63323745 |
| 147 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.62761410 |
| 148 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.62761410 |
| 149 | epithelial cell-cell adhesion (GO:0090136) | 2.60338510 |
| 150 | regulation of extracellular matrix organization (GO:1903053) | 2.58346937 |
| 151 | cellular response to unfolded protein (GO:0034620) | 2.56609644 |
| 152 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.54659919 |
| 153 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.53940122 |
| 154 | desmosome organization (GO:0002934) | 2.53836894 |
| 155 | protein maturation by protein folding (GO:0022417) | 2.53679456 |
| 156 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.52764258 |
| 157 | apoptotic process involved in morphogenesis (GO:0060561) | 2.50566525 |
| 158 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.48583107 |
| 159 | regulation of histone H3-K27 methylation (GO:0061085) | 2.48572273 |
| 160 | glucose catabolic process (GO:0006007) | 2.46360152 |
| 161 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.45868817 |
| 162 | modulation by virus of host morphology or physiology (GO:0019048) | 2.45373947 |
| 163 | NADH metabolic process (GO:0006734) | 2.44526235 |
| 164 | embryo implantation (GO:0007566) | 2.43816254 |
| 165 | peptidyl-proline hydroxylation (GO:0019511) | 2.42091793 |
| 166 | membrane protein ectodomain proteolysis (GO:0006509) | 2.41247223 |
| 167 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.39694451 |
| 168 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.39367748 |
| 169 | modulation by virus of host process (GO:0019054) | 2.37844658 |
| 170 | endodermal cell differentiation (GO:0035987) | 2.37815039 |
| 171 | protein hydroxylation (GO:0018126) | 2.37660350 |
| 172 | cellular response to osmotic stress (GO:0071470) | 2.37389611 |
| 173 | protein targeting to plasma membrane (GO:0072661) | 2.37261563 |
| 174 | proline metabolic process (GO:0006560) | 2.36366429 |
| 175 | sodium ion export (GO:0071436) | 2.36220034 |
| 176 | activation of Rac GTPase activity (GO:0032863) | 2.34873918 |
| 177 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.34594898 |
| 178 | adhesion of symbiont to host (GO:0044406) | 2.33482905 |
| 179 | cellular response to topologically incorrect protein (GO:0035967) | 2.32669557 |
| 180 | positive regulation of protein dephosphorylation (GO:0035307) | 2.32641447 |
| 181 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.31188523 |
| 182 | cortical actin cytoskeleton organization (GO:0030866) | 2.31128049 |
| 183 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.26601573 |
| 184 | glucose 6-phosphate metabolic process (GO:0051156) | 2.25823839 |
| 185 | membrane raft organization (GO:0031579) | 2.25580461 |
| 186 | mitotic chromosome condensation (GO:0007076) | 2.25412785 |
| 187 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.22060969 |
| 188 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.20841586 |
| 189 | regulation of plasminogen activation (GO:0010755) | 2.20734036 |
| 190 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.20348998 |
| 191 | positive regulation of myotube differentiation (GO:0010831) | 2.20213564 |
| 192 | hyaluronan metabolic process (GO:0030212) | 2.18701488 |
| 193 | substrate-dependent cell migration (GO:0006929) | 2.16845480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.72612869 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.31701998 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.00227026 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.80845526 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.29022039 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.94546226 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.74342474 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.74176164 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.59512359 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.26566591 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21212297 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.18281929 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.09777881 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.03829778 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.99123222 |
| 16 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.96007540 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91269226 |
| 18 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.85931902 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81418518 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75367204 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.73740418 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73617415 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.72329782 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70417734 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69672965 |
| 26 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68774596 |
| 27 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.67695317 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65017809 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64691625 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61791218 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.60212320 |
| 32 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.59999386 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59489893 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58096719 |
| 35 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55961295 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52795759 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.50415624 |
| 38 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.49284631 |
| 39 | ATF3_27146783_Chip-Seq_COLON_Human | 1.47886504 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47632236 |
| 41 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.47572850 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46845216 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46243285 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46196972 |
| 45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43993253 |
| 46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42698082 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42463633 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42218644 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40243465 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40154126 |
| 51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39127434 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38317704 |
| 53 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.38136912 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.37965768 |
| 55 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36264708 |
| 56 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.36142056 |
| 57 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.35967235 |
| 58 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35740528 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33933167 |
| 60 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.33471660 |
| 61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32647332 |
| 62 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31001244 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.30853861 |
| 64 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.30496857 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.30220333 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27676891 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26708683 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25448325 |
| 69 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.25289284 |
| 70 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24078800 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23942649 |
| 72 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23499197 |
| 73 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23386025 |
| 74 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23309416 |
| 75 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22476818 |
| 76 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.22386360 |
| 77 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.22315264 |
| 78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21690889 |
| 79 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21160002 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18688959 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18389980 |
| 82 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17592709 |
| 83 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16936886 |
| 84 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16936886 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16895245 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16648993 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16544078 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16445564 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16257611 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16157676 |
| 91 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.15191615 |
| 92 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15046991 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14795860 |
| 94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14773968 |
| 95 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14146837 |
| 96 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13625194 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13190523 |
| 98 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13020240 |
| 99 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12562359 |
| 100 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.11989309 |
| 101 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11097635 |
| 102 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.10797374 |
| 103 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09872848 |
| 104 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09517887 |
| 105 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09083391 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08824499 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 1.08718509 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08522689 |
| 109 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08244771 |
| 110 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.08214835 |
| 111 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06909613 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06640043 |
| 113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.06448119 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05631607 |
| 115 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05293502 |
| 116 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.04430057 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 1.04330712 |
| 118 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.04205092 |
| 119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03729465 |
| 120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03729465 |
| 121 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03573413 |
| 122 | MYB_26560356_Chip-Seq_TH1_Human | 1.03520885 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03067937 |
| 124 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02749329 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02681385 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02549657 |
| 127 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01751118 |
| 128 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01521133 |
| 129 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.99934524 |
| 130 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99822745 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99731474 |
| 132 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99600708 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99041415 |
| 134 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98853447 |
| 135 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98675139 |
| 136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97516959 |
| 137 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97119768 |
| 138 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96481617 |
| 139 | P68_20966046_ChIP-Seq_HELA_Human | 0.96457816 |
| 140 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96128452 |
| 141 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.95932047 |
| 142 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95340990 |
| 143 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95109068 |
| 144 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93888136 |
| 145 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93120179 |
| 146 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93037092 |
| 147 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92508759 |
| 148 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92010791 |
| 149 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.92008769 |
| 150 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91991616 |
| 151 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.91252864 |
| 152 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91119509 |
| 153 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90906235 |
| 154 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90863858 |
| 155 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90726349 |
| 156 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.90505942 |
| 157 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90388145 |
| 158 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89962560 |
| 159 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88874114 |
| 160 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88590906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.34036560 |
| 2 | MP0005360_urolithiasis | 4.15442038 |
| 3 | MP0009840_abnormal_foam_cell | 3.53842108 |
| 4 | MP0005365_abnormal_bile_salt | 3.35772036 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.23844588 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.19342731 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 2.56013458 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.50394555 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.41677657 |
| 10 | MP0003252_abnormal_bile_duct | 2.40500421 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.26042448 |
| 12 | MP0005083_abnormal_biliary_tract | 2.25755048 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.16011150 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.15202754 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.10423183 |
| 16 | MP0004272_abnormal_basement_membrane | 2.05718799 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.04563772 |
| 18 | MP0005257_abnormal_intraocular_pressure | 1.99756170 |
| 19 | MP0008260_abnormal_autophagy | 1.99426571 |
| 20 | MP0005332_abnormal_amino_acid | 1.99097800 |
| 21 | MP0003091_abnormal_cell_migration | 1.95786046 |
| 22 | MP0003186_abnormal_redox_activity | 1.93283758 |
| 23 | MP0001958_emphysema | 1.87720614 |
| 24 | MP0005670_abnormal_white_adipose | 1.82723182 |
| 25 | MP0001849_ear_inflammation | 1.77919837 |
| 26 | MP0003436_decreased_susceptibility_to | 1.76291451 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.76183237 |
| 28 | MP0000609_abnormal_liver_physiology | 1.74662446 |
| 29 | MP0006054_spinal_hemorrhage | 1.72800400 |
| 30 | MP0004233_abnormal_muscle_weight | 1.72421928 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.71457528 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.68622810 |
| 33 | MP0003195_calcinosis | 1.64059596 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.62787252 |
| 35 | MP0005275_abnormal_skin_tensile | 1.62746585 |
| 36 | MP0004858_abnormal_nervous_system | 1.62061422 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.61949460 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.59838609 |
| 39 | MP0003011_delayed_dark_adaptation | 1.56838123 |
| 40 | MP0009278_abnormal_bone_marrow | 1.51943759 |
| 41 | MP0000751_myopathy | 1.51738484 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.50594857 |
| 43 | MP0005409_darkened_coat_color | 1.49375359 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.48724631 |
| 45 | MP0002060_abnormal_skin_morphology | 1.47842733 |
| 46 | MP0005623_abnormal_meninges_morphology | 1.47614059 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.45704109 |
| 48 | MP0001853_heart_inflammation | 1.41762111 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.40790683 |
| 50 | MP0003453_abnormal_keratinocyte_physiol | 1.40628506 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.38838153 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.33724394 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32793392 |
| 54 | MP0000678_abnormal_parathyroid_gland | 1.31280711 |
| 55 | MP0000733_abnormal_muscle_development | 1.30961563 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.27757395 |
| 57 | MP0001764_abnormal_homeostasis | 1.27649219 |
| 58 | MP0000767_abnormal_smooth_muscle | 1.27110020 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 1.25684076 |
| 60 | MP0005503_abnormal_tendon_morphology | 1.23583742 |
| 61 | MP0008469_abnormal_protein_level | 1.23311988 |
| 62 | MP0000685_abnormal_immune_system | 1.23073986 |
| 63 | MP0005220_abnormal_exocrine_pancreas | 1.21320539 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.19788119 |
| 65 | MP0003279_aneurysm | 1.18582003 |
| 66 | MP0000759_abnormal_skeletal_muscle | 1.17860459 |
| 67 | MP0002796_impaired_skin_barrier | 1.17215981 |
| 68 | MP0000598_abnormal_liver_morphology | 1.15714897 |
| 69 | MP0004130_abnormal_muscle_cell | 1.15426814 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.15023496 |
| 71 | MP0002896_abnormal_bone_mineralization | 1.14884680 |
| 72 | MP0004087_abnormal_muscle_fiber | 1.14372366 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.12338660 |
| 74 | MP0003303_peritoneal_inflammation | 1.11561669 |
| 75 | MP0002419_abnormal_innate_immunity | 1.10808726 |
| 76 | MP0001915_intracranial_hemorrhage | 1.09366090 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 1.08684156 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 1.07679341 |
| 79 | MP0003724_increased_susceptibility_to | 1.06704379 |
| 80 | MP0000747_muscle_weakness | 1.06629713 |
| 81 | MP0005408_hypopigmentation | 1.06287967 |
| 82 | MP0009785_altered_susceptibility_to | 1.03885178 |
| 83 | MP0009763_increased_sensitivity_to | 1.02495801 |
| 84 | MP0003763_abnormal_thymus_physiology | 1.02262545 |
| 85 | MP0000467_abnormal_esophagus_morphology | 1.01739880 |
| 86 | MP0005025_abnormal_response_to | 1.00882712 |
| 87 | MP0005330_cardiomyopathy | 0.99475580 |
| 88 | MP0002933_joint_inflammation | 0.98916190 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.98793243 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.96349436 |
| 91 | MP0001730_embryonic_growth_arrest | 0.95613552 |
| 92 | MP0000858_altered_metastatic_potential | 0.94907118 |
| 93 | MP0005387_immune_system_phenotype | 0.94601799 |
| 94 | MP0001790_abnormal_immune_system | 0.94601799 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.94059114 |
| 96 | MP0001542_abnormal_bone_strength | 0.93660390 |
| 97 | MP0009384_cardiac_valve_regurgitation | 0.93616756 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.92995633 |
| 99 | MP0003828_pulmonary_edema | 0.92748572 |
| 100 | MP0005621_abnormal_cell_physiology | 0.92512568 |
| 101 | MP0005501_abnormal_skin_physiology | 0.92490628 |
| 102 | MP0010630_abnormal_cardiac_muscle | 0.91782870 |
| 103 | MP0005451_abnormal_body_composition | 0.90951269 |
| 104 | MP0005671_abnormal_response_to | 0.90652879 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 0.90347074 |
| 106 | MP0003868_abnormal_feces_composition | 0.89942584 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.89593069 |
| 108 | MP0000343_altered_response_to | 0.89459053 |
| 109 | MP0009780_abnormal_chondrocyte_physiolo | 0.87439514 |
| 110 | MP0003329_amyloid_beta_deposits | 0.87325098 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.87253970 |
| 112 | MP0006138_congestive_heart_failure | 0.87026887 |
| 113 | MP0009379_abnormal_foot_pigmentation | 0.86574613 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86153392 |
| 115 | MP0009053_abnormal_anal_canal | 0.86008287 |
| 116 | MP0001756_abnormal_urination | 0.85365643 |
| 117 | MP0000689_abnormal_spleen_morphology | 0.84391476 |
| 118 | MP0005000_abnormal_immune_tolerance | 0.83952579 |
| 119 | MP0002166_altered_tumor_susceptibility | 0.83660942 |
| 120 | MP0004147_increased_porphyrin_level | 0.83419998 |
| 121 | MP0003448_altered_tumor_morphology | 0.83101566 |
| 122 | MP0000465_gastrointestinal_hemorrhage | 0.81408834 |
| 123 | MP0010155_abnormal_intestine_physiology | 0.81183377 |
| 124 | MP0001800_abnormal_humoral_immune | 0.81166539 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.81143009 |
| 126 | MP0000749_muscle_degeneration | 0.80790273 |
| 127 | MP0005397_hematopoietic_system_phenotyp | 0.80662029 |
| 128 | MP0001545_abnormal_hematopoietic_system | 0.80662029 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.80390647 |
| 130 | MP0006082_CNS_inflammation | 0.80369491 |
| 131 | MP0003075_altered_response_to | 0.80016790 |
| 132 | MP0000681_abnormal_thyroid_gland | 0.79638086 |
| 133 | MP0004036_abnormal_muscle_relaxation | 0.79569810 |
| 134 | MP0000604_amyloidosis | 0.79093320 |
| 135 | MP0005023_abnormal_wound_healing | 0.78988580 |
| 136 | MP0002452_abnormal_antigen_presenting | 0.78963308 |
| 137 | MP0004084_abnormal_cardiac_muscle | 0.78151278 |
| 138 | MP0001216_abnormal_epidermal_layer | 0.77995764 |
| 139 | MP0003566_abnormal_cell_adhesion | 0.77745122 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.76867115 |
| 141 | MP0002970_abnormal_white_adipose | 0.76633300 |
| 142 | MP0005334_abnormal_fat_pad | 0.76064016 |
| 143 | MP0000750_abnormal_muscle_regeneration | 0.75595448 |
| 144 | MP0002722_abnormal_immune_system | 0.75339520 |
| 145 | MP0002723_abnormal_immune_serum | 0.75221743 |
| 146 | MP0003795_abnormal_bone_structure | 0.75008832 |
| 147 | MP0002269_muscular_atrophy | 0.75003936 |
| 148 | MP0005375_adipose_tissue_phenotype | 0.74141807 |
| 149 | MP0000490_abnormal_crypts_of | 0.74090315 |
| 150 | MP0002971_abnormal_brown_adipose | 0.74024279 |
| 151 | MP0004510_myositis | 0.73712124 |
| 152 | MP0004947_skin_inflammation | 0.73539235 |
| 153 | MP0005164_abnormal_response_to | 0.73023720 |
| 154 | MP0002405_respiratory_system_inflammati | 0.72891292 |
| 155 | MP0002837_dystrophic_cardiac_calcinosis | 0.72678482 |
| 156 | MP0002420_abnormal_adaptive_immunity | 0.72057971 |
| 157 | MP0002078_abnormal_glucose_homeostasis | 0.71857692 |
| 158 | MP0005165_increased_susceptibility_to | 0.71601597 |
| 159 | MP0002132_abnormal_respiratory_system | 0.71462371 |
| 160 | MP0001243_abnormal_dermal_layer | 0.71078169 |
| 161 | MP0000249_abnormal_blood_vessel | 0.70938186 |
| 162 | MP0009115_abnormal_fat_cell | 0.70371875 |
| 163 | MP0009931_abnormal_skin_appearance | 0.70253189 |
| 164 | MP0005508_abnormal_skeleton_morphology | 0.70248676 |
| 165 | MP0010352_gastrointestinal_tract_polyps | 0.69933501 |
| 166 | MP0005390_skeleton_phenotype | 0.69895858 |
| 167 | MP0009764_decreased_sensitivity_to | 0.69320684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.53800852 |
| 2 | Xanthomatosis (HP:0000991) | 4.08110408 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.00186569 |
| 4 | Hypoglycemic coma (HP:0001325) | 3.88927659 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.85534373 |
| 6 | Distal lower limb muscle weakness (HP:0009053) | 3.84397648 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 3.81697653 |
| 8 | Deep venous thrombosis (HP:0002625) | 3.74473104 |
| 9 | Ketosis (HP:0001946) | 3.54526706 |
| 10 | Hyperammonemia (HP:0001987) | 3.53350479 |
| 11 | Flat acetabular roof (HP:0003180) | 3.49892944 |
| 12 | Upper limb amyotrophy (HP:0009129) | 3.39387368 |
| 13 | Distal upper limb amyotrophy (HP:0007149) | 3.39387368 |
| 14 | Achilles tendon contracture (HP:0001771) | 3.34570375 |
| 15 | Hyperglycinuria (HP:0003108) | 3.34465136 |
| 16 | Ketoacidosis (HP:0001993) | 3.33432619 |
| 17 | Vertebral compression fractures (HP:0002953) | 3.32159680 |
| 18 | Hand muscle atrophy (HP:0009130) | 3.15244130 |
| 19 | Complement deficiency (HP:0004431) | 3.15227368 |
| 20 | Obstructive sleep apnea (HP:0002870) | 3.11456999 |
| 21 | Abnormality of the Achilles tendon (HP:0005109) | 3.10673207 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.09233013 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.03360068 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 2.99046113 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.97795638 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 2.97795638 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 2.97005115 |
| 28 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.88934800 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 2.87439907 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 2.87124129 |
| 31 | Vacuolated lymphocytes (HP:0001922) | 2.86561050 |
| 32 | Hypobetalipoproteinemia (HP:0003563) | 2.85159257 |
| 33 | Dicarboxylic aciduria (HP:0003215) | 2.80828898 |
| 34 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.80828898 |
| 35 | Stridor (HP:0010307) | 2.79484844 |
| 36 | Generalized aminoaciduria (HP:0002909) | 2.78066794 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 2.77962243 |
| 38 | Abnormality of complement system (HP:0005339) | 2.77547479 |
| 39 | Spinal rigidity (HP:0003306) | 2.75105035 |
| 40 | Abnormality of carpal bone ossification (HP:0006257) | 2.74016804 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.73478892 |
| 42 | Increased connective tissue (HP:0009025) | 2.72290928 |
| 43 | Hypolipoproteinemia (HP:0010981) | 2.72233280 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.68422250 |
| 45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.67208352 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.67208352 |
| 47 | Joint hemorrhage (HP:0005261) | 2.62656417 |
| 48 | Axonal loss (HP:0003447) | 2.61854194 |
| 49 | Spinal cord compression (HP:0002176) | 2.61149445 |
| 50 | Late onset (HP:0003584) | 2.60492801 |
| 51 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.59594284 |
| 52 | Myocardial infarction (HP:0001658) | 2.59159767 |
| 53 | Vascular tortuosity (HP:0004948) | 2.58418962 |
| 54 | Increased variability in muscle fiber diameter (HP:0003557) | 2.50316416 |
| 55 | Hyperglycinemia (HP:0002154) | 2.49690779 |
| 56 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.46903393 |
| 57 | Muscle fiber splitting (HP:0003555) | 2.46817282 |
| 58 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.46630049 |
| 59 | Hyperacusis (HP:0010780) | 2.46621108 |
| 60 | Arterial tortuosity (HP:0005116) | 2.46529981 |
| 61 | Cerebral aneurysm (HP:0004944) | 2.46355546 |
| 62 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.46339058 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.46291395 |
| 64 | Distal lower limb amyotrophy (HP:0008944) | 2.43277197 |
| 65 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.42063507 |
| 66 | Abnormal ossification of hand bones (HP:0005921) | 2.41333390 |
| 67 | Myoglobinuria (HP:0002913) | 2.40767917 |
| 68 | Abnormality of methionine metabolism (HP:0010901) | 2.40436952 |
| 69 | Hypercholesterolemia (HP:0003124) | 2.39470537 |
| 70 | Hyperbilirubinemia (HP:0002904) | 2.37421273 |
| 71 | Diaphragmatic weakness (HP:0009113) | 2.37000924 |
| 72 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36404644 |
| 73 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36404644 |
| 74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36404644 |
| 75 | Fat malabsorption (HP:0002630) | 2.36178610 |
| 76 | Elbow flexion contracture (HP:0002987) | 2.35374583 |
| 77 | Cervical subluxation (HP:0003308) | 2.34469961 |
| 78 | Aortic aneurysm (HP:0004942) | 2.34233502 |
| 79 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.33801703 |
| 80 | Fragile skin (HP:0001030) | 2.33390143 |
| 81 | Ankle contracture (HP:0006466) | 2.27795842 |
| 82 | Hypoglycemic seizures (HP:0002173) | 2.27362805 |
| 83 | Abnormality of the acetabulum (HP:0003170) | 2.26507426 |
| 84 | Aortic dissection (HP:0002647) | 2.25938490 |
| 85 | Wormian bones (HP:0002645) | 2.25586465 |
| 86 | Beaking of vertebral bodies (HP:0004568) | 2.24768740 |
| 87 | Abnormality of purine metabolism (HP:0004352) | 2.24323011 |
| 88 | Abnormality of nucleobase metabolism (HP:0010932) | 2.23287147 |
| 89 | Broad face (HP:0000283) | 2.22395428 |
| 90 | Opisthotonus (HP:0002179) | 2.22135723 |
| 91 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.21215418 |
| 92 | Type 1 muscle fiber predominance (HP:0003803) | 2.20421740 |
| 93 | Thoracic kyphosis (HP:0002942) | 2.19810001 |
| 94 | Coxa vara (HP:0002812) | 2.19062714 |
| 95 | Dilatation of the ascending aorta (HP:0005111) | 2.18983665 |
| 96 | Scapular winging (HP:0003691) | 2.16388304 |
| 97 | Disproportionate tall stature (HP:0001519) | 2.15506290 |
| 98 | Asymmetry of the thorax (HP:0001555) | 2.12973774 |
| 99 | Multiple enchondromatosis (HP:0005701) | 2.11463552 |
| 100 | Metabolic acidosis (HP:0001942) | 2.11369523 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 2.10224335 |
| 102 | Nonimmune hydrops fetalis (HP:0001790) | 2.09796978 |
| 103 | Rhabdomyolysis (HP:0003201) | 2.09625669 |
| 104 | Osteolytic defects of the hand bones (HP:0009699) | 2.09353457 |
| 105 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09353457 |
| 106 | Limb-girdle muscle atrophy (HP:0003797) | 2.08707113 |
| 107 | Atrophic scars (HP:0001075) | 2.08465182 |
| 108 | Epidermoid cyst (HP:0200040) | 2.07432991 |
| 109 | Blue sclerae (HP:0000592) | 2.04910679 |
| 110 | Glomerulonephritis (HP:0000099) | 2.04810349 |
| 111 | Aneurysm (HP:0002617) | 2.03612962 |
| 112 | Spontaneous hematomas (HP:0007420) | 2.03578373 |
| 113 | Ulnar bowing (HP:0003031) | 2.02303490 |
| 114 | Increased serum ferritin (HP:0003281) | 2.01988619 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 2.00314945 |
| 116 | Steatorrhea (HP:0002570) | 1.98409436 |
| 117 | Thin bony cortex (HP:0002753) | 1.97954671 |
| 118 | Generalized amyotrophy (HP:0003700) | 1.97813196 |
| 119 | Bladder diverticulum (HP:0000015) | 1.97091655 |
| 120 | Vascular calcification (HP:0004934) | 1.96935087 |
| 121 | Nausea (HP:0002018) | 1.96910255 |
| 122 | Pancreatitis (HP:0001733) | 1.95663559 |
| 123 | Hypertriglyceridemia (HP:0002155) | 1.94626709 |
| 124 | Mitral regurgitation (HP:0001653) | 1.92101570 |
| 125 | Hepatic necrosis (HP:0002605) | 1.91552331 |
| 126 | Delayed CNS myelination (HP:0002188) | 1.91454046 |
| 127 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.91215881 |
| 128 | Lethargy (HP:0001254) | 1.90898688 |
| 129 | Hemorrhage of the eye (HP:0011885) | 1.90437721 |
| 130 | Mitral stenosis (HP:0001718) | 1.89579783 |
| 131 | Hepatocellular carcinoma (HP:0001402) | 1.89225014 |
| 132 | Aplasia of the musculature (HP:0100854) | 1.89089949 |
| 133 | Knee flexion contracture (HP:0006380) | 1.88896859 |
| 134 | Genu recurvatum (HP:0002816) | 1.88443591 |
| 135 | Chronic otitis media (HP:0000389) | 1.88371321 |
| 136 | Spondylolisthesis (HP:0003302) | 1.87435593 |
| 137 | Shallow orbits (HP:0000586) | 1.87416296 |
| 138 | Abnormal hand bone ossification (HP:0010660) | 1.86633713 |
| 139 | Protrusio acetabuli (HP:0003179) | 1.85651306 |
| 140 | Polycythemia (HP:0001901) | 1.85233875 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.84933040 |
| 142 | Cardiovascular calcification (HP:0011915) | 1.83258942 |
| 143 | Gout (HP:0001997) | 1.83130544 |
| 144 | Hip contracture (HP:0003273) | 1.82848483 |
| 145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82458287 |
| 146 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82274512 |
| 147 | Vomiting (HP:0002013) | 1.81218989 |
| 148 | Epistaxis (HP:0000421) | 1.81136280 |
| 149 | Mesangial abnormality (HP:0001966) | 1.79250051 |
| 150 | Conjugated hyperbilirubinemia (HP:0002908) | 1.79212652 |
| 151 | Difficulty running (HP:0009046) | 1.79027034 |
| 152 | Short nail (HP:0001799) | 1.77507622 |
| 153 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77425635 |
| 154 | Biconcave vertebral bodies (HP:0004586) | 1.77339219 |
| 155 | Hyperparathyroidism (HP:0000843) | 1.76892106 |
| 156 | Proximal tubulopathy (HP:0000114) | 1.75319453 |
| 157 | Back pain (HP:0003418) | 1.75237421 |
| 158 | Skin nodule (HP:0200036) | 1.75206234 |
| 159 | Impaired platelet aggregation (HP:0003540) | 1.74599070 |
| 160 | Abnormal platelet function (HP:0011869) | 1.74599070 |
| 161 | Mitral valve prolapse (HP:0001634) | 1.74523158 |
| 162 | Thrombocytosis (HP:0001894) | 1.73930467 |
| 163 | Abnormality of serum amino acid levels (HP:0003112) | 1.72950266 |
| 164 | Cardiomegaly (HP:0001640) | 1.72156927 |
| 165 | Exercise-induced myalgia (HP:0003738) | 1.71899191 |
| 166 | Abnormality of the lumbar spine (HP:0100712) | 1.71087301 |
| 167 | Cerebral palsy (HP:0100021) | 1.70918961 |
| 168 | Peritonitis (HP:0002586) | 1.70778138 |
| 169 | Urticaria (HP:0001025) | 1.69927195 |
| 170 | J-shaped sella turcica (HP:0002680) | 1.69555800 |
| 171 | Abnormality of the nasal mucosa (HP:0000433) | 1.69508956 |
| 172 | Insomnia (HP:0100785) | 1.68896812 |
| 173 | Spastic diplegia (HP:0001264) | 1.67764874 |
| 174 | Slender build (HP:0001533) | 1.67471617 |
| 175 | Abnormal vertebral ossification (HP:0100569) | 1.67412894 |
| 176 | Abnormality of the thoracic spine (HP:0100711) | 1.67400944 |
| 177 | Abnormality of oral frenula (HP:0000190) | 1.64951087 |
| 178 | Rough bone trabeculation (HP:0100670) | 1.64877311 |
| 179 | Metatarsus adductus (HP:0001840) | 1.64615463 |
| 180 | Foot dorsiflexor weakness (HP:0009027) | 1.63539930 |
| 181 | Abnormality of glycolipid metabolism (HP:0010969) | 1.62604471 |
| 182 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.62604471 |
| 183 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.62604471 |
| 184 | Advanced eruption of teeth (HP:0006288) | 1.61440746 |
| 185 | Syringomyelia (HP:0003396) | 1.60301158 |
| 186 | Spinal cord lesions (HP:0100561) | 1.60301158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.68496205 |
| 2 | TRIB3 | 3.60273274 |
| 3 | ERN1 | 3.40697086 |
| 4 | PKN2 | 3.35696342 |
| 5 | PRPF4B | 3.11945084 |
| 6 | SMG1 | 3.03643268 |
| 7 | FLT3 | 2.85272142 |
| 8 | ICK | 2.59493360 |
| 9 | MAP4K1 | 2.40151387 |
| 10 | NME2 | 2.38285091 |
| 11 | PIK3CG | 2.25553842 |
| 12 | PDGFRA | 2.22075234 |
| 13 | CDK12 | 2.17561571 |
| 14 | MAP2K3 | 2.17194299 |
| 15 | IRAK3 | 2.12780622 |
| 16 | SIK1 | 1.93171911 |
| 17 | KDR | 1.82418515 |
| 18 | TTN | 1.81276098 |
| 19 | TYK2 | 1.71493161 |
| 20 | TAOK3 | 1.69982010 |
| 21 | FGFR4 | 1.66903748 |
| 22 | TGFBR2 | 1.66514840 |
| 23 | LRRK2 | 1.64197531 |
| 24 | EPHA2 | 1.60349384 |
| 25 | ZAP70 | 1.53698457 |
| 26 | TESK2 | 1.51570359 |
| 27 | KSR2 | 1.51039492 |
| 28 | TBK1 | 1.49562258 |
| 29 | PTK6 | 1.48407696 |
| 30 | NEK9 | 1.46120661 |
| 31 | STK10 | 1.44010907 |
| 32 | KIT | 1.41084210 |
| 33 | EEF2K | 1.38833967 |
| 34 | TESK1 | 1.35506311 |
| 35 | MAP3K13 | 1.35428277 |
| 36 | MAP3K3 | 1.32939426 |
| 37 | BTK | 1.26754013 |
| 38 | DDR2 | 1.25151044 |
| 39 | EPHB1 | 1.23714755 |
| 40 | PIM2 | 1.23165830 |
| 41 | CSF1R | 1.22220658 |
| 42 | MAP3K10 | 1.19658139 |
| 43 | PTK2 | 1.17686789 |
| 44 | MAPKAPK3 | 1.17438556 |
| 45 | JAK3 | 1.16963555 |
| 46 | MTOR | 1.16289412 |
| 47 | MST1R | 1.10762633 |
| 48 | STK16 | 1.10213548 |
| 49 | RPS6KA4 | 1.06389741 |
| 50 | BLK | 1.06155807 |
| 51 | ARAF | 1.05579484 |
| 52 | MAP3K1 | 1.05040444 |
| 53 | LATS2 | 1.04747146 |
| 54 | CDC42BPA | 1.02146134 |
| 55 | MAP3K11 | 1.00969485 |
| 56 | PRKD2 | 1.00331905 |
| 57 | EIF2AK3 | 0.96816702 |
| 58 | MAP3K14 | 0.95972396 |
| 59 | NLK | 0.95728471 |
| 60 | SCYL2 | 0.90655778 |
| 61 | IRAK4 | 0.90097810 |
| 62 | MOS | 0.88988840 |
| 63 | MYLK | 0.88866172 |
| 64 | SIK3 | 0.88730197 |
| 65 | STK38 | 0.88533996 |
| 66 | JAK2 | 0.87316809 |
| 67 | TAOK2 | 0.85751066 |
| 68 | TAOK1 | 0.84668180 |
| 69 | PAK4 | 0.82992489 |
| 70 | FGFR3 | 0.82665639 |
| 71 | PASK | 0.82532125 |
| 72 | MAPK11 | 0.82296934 |
| 73 | DYRK1B | 0.81534062 |
| 74 | MAP3K8 | 0.81456121 |
| 75 | PDK3 | 0.80260193 |
| 76 | PDK4 | 0.80260193 |
| 77 | ITK | 0.80077793 |
| 78 | PDPK1 | 0.79776246 |
| 79 | TEC | 0.79481761 |
| 80 | IKBKE | 0.77062142 |
| 81 | NTRK1 | 0.76559180 |
| 82 | GRK6 | 0.74267406 |
| 83 | ILK | 0.74032433 |
| 84 | INSRR | 0.72489665 |
| 85 | JAK1 | 0.71306707 |
| 86 | PAK2 | 0.70919241 |
| 87 | LMTK2 | 0.67165893 |
| 88 | MAPK12 | 0.67057480 |
| 89 | MAP3K6 | 0.66807485 |
| 90 | RIPK1 | 0.66748685 |
| 91 | RET | 0.66335949 |
| 92 | CSK | 0.65000720 |
| 93 | MAP2K2 | 0.64577546 |
| 94 | RIPK4 | 0.64262426 |
| 95 | MET | 0.63445908 |
| 96 | MAP3K2 | 0.62416062 |
| 97 | MARK2 | 0.61563843 |
| 98 | TRPM7 | 0.61419402 |
| 99 | EIF2AK1 | 0.59885668 |
| 100 | EPHA3 | 0.59646742 |
| 101 | STK4 | 0.59579128 |
| 102 | RPS6KA2 | 0.58527819 |
| 103 | IRAK1 | 0.58084230 |
| 104 | CDK7 | 0.56659973 |
| 105 | IKBKB | 0.56451946 |
| 106 | LYN | 0.55711932 |
| 107 | PRKD3 | 0.55373693 |
| 108 | PDGFRB | 0.55328242 |
| 109 | LCK | 0.54733115 |
| 110 | IRAK2 | 0.54512789 |
| 111 | MAPK15 | 0.52097239 |
| 112 | CDK8 | 0.51931682 |
| 113 | MELK | 0.51490529 |
| 114 | MAP2K6 | 0.49780989 |
| 115 | MAP3K7 | 0.49507331 |
| 116 | MAPK4 | 0.49217855 |
| 117 | TLK1 | 0.49109844 |
| 118 | SYK | 0.47064949 |
| 119 | MAP2K1 | 0.46291448 |
| 120 | ABL2 | 0.45548181 |
| 121 | BMX | 0.45333765 |
| 122 | PRKD1 | 0.43932524 |
| 123 | PRKG2 | 0.43864232 |
| 124 | DMPK | 0.43815615 |
| 125 | LIMK1 | 0.43785795 |
| 126 | HCK | 0.43607727 |
| 127 | PIM1 | 0.43196225 |
| 128 | RPS6KB2 | 0.42920334 |
| 129 | CDK6 | 0.42699762 |
| 130 | PDK2 | 0.42666134 |
| 131 | RPS6KC1 | 0.41901486 |
| 132 | RPS6KL1 | 0.41901486 |
| 133 | TXK | 0.41619929 |
| 134 | CLK1 | 0.41369239 |
| 135 | ACVR1B | 0.40163716 |
| 136 | BRSK2 | 0.39637302 |
| 137 | WNK4 | 0.39463645 |
| 138 | AKT2 | 0.38594652 |
| 139 | CDK9 | 0.38574255 |
| 140 | HIPK2 | 0.38300920 |
| 141 | BUB1 | 0.38284995 |
| 142 | CDK4 | 0.37409191 |
| 143 | MAPKAPK2 | 0.36000465 |
| 144 | PDK1 | 0.35763814 |
| 145 | RAF1 | 0.34734655 |
| 146 | PRKAA2 | 0.34139850 |
| 147 | ROCK2 | 0.34099663 |
| 148 | MAP3K5 | 0.32087092 |
| 149 | TGFBR1 | 0.30515081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.95438010 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.77955653 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.67303678 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.52645093 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34597883 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.29253868 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.29144647 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.19916018 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.17870477 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.15226470 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.08931728 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.01867133 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96340011 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93184692 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.90947950 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.90846659 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.88691951 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.81046344 |
| 19 | Bladder cancer_Homo sapiens_hsa05219 | 1.76214042 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.75621150 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.73979326 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.71848024 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69054060 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68716972 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.66275642 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.64237510 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.63223083 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61067682 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.59503875 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.58825378 |
| 31 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.56795930 |
| 32 | Focal adhesion_Homo sapiens_hsa04510 | 1.56788451 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54564381 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50408784 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50272886 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48999110 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.48883653 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.48130079 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.47050491 |
| 40 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.45266764 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44690035 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.43886471 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.43651051 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41275211 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40645261 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.35028961 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.34319756 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.34082763 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.31597618 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31089328 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30783970 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29285394 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.27556080 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27352784 |
| 55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.27252949 |
| 56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26977456 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 1.25824237 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25455017 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.25434104 |
| 60 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.23716160 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.19850909 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19490643 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19296672 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18905129 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.15492795 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15104793 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.14539756 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 1.14094625 |
| 69 | Glioma_Homo sapiens_hsa05214 | 1.13892304 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12183420 |
| 71 | Protein export_Homo sapiens_hsa03060 | 1.11667989 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07257901 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04800697 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.04233454 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 1.04100065 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03294143 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 1.02508890 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 1.01799561 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98924957 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.98784840 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.98559268 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98452399 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.98211538 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97989914 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97869979 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97326810 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96164074 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93873302 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93024996 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.92821915 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | 0.92214985 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92164429 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91891051 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91504580 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91200226 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89764456 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88477897 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88184187 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.86811190 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86623613 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85703622 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85626292 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.85518354 |
| 104 | Ribosome_Homo sapiens_hsa03010 | 0.85076800 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84316251 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83420087 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83095498 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79849671 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79805897 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78632505 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.78250487 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75770136 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.75194515 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74515278 |
| 115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74421799 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.74285440 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73364665 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72771518 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72738712 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.71132185 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70697160 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70082332 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69961011 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69934064 |
| 125 | DNA replication_Homo sapiens_hsa03030 | 0.68572419 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68190417 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68134721 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68081838 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67798035 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67579347 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62749869 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.61725523 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60332176 |
| 134 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60208363 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57139627 |
| 136 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.56244312 |
| 137 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56023082 |
| 138 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55277045 |
| 139 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55090783 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54576969 |
| 141 | Base excision repair_Homo sapiens_hsa03410 | 0.54374086 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53461726 |
| 143 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52663612 |
| 144 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51092332 |
| 145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50972741 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50349589 |
| 147 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47772567 |
| 148 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47229919 |
| 149 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45651289 |
| 150 | Insulin resistance_Homo sapiens_hsa04931 | 0.42271375 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40525029 |
| 152 | Leishmaniasis_Homo sapiens_hsa05140 | 0.38317280 |
| 153 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37382187 |
| 154 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36089954 |
| 155 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.34830603 |
| 156 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32903073 |
| 157 | Legionellosis_Homo sapiens_hsa05134 | 0.31362761 |
| 158 | Proteasome_Homo sapiens_hsa03050 | 0.29741516 |
| 159 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26727107 |
| 160 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23261889 |
| 161 | Apoptosis_Homo sapiens_hsa04210 | 0.22453709 |
| 162 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.20682651 |
| 163 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.18643483 |
| 164 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.18341262 |
| 165 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18301151 |
| 166 | Pertussis_Homo sapiens_hsa05133 | 0.17820541 |
| 167 | Measles_Homo sapiens_hsa05162 | 0.16855233 |
| 168 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.15521945 |
| 169 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.15231898 |
| 170 | Malaria_Homo sapiens_hsa05144 | 0.13295853 |

